Concepedia

Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.

Alireza Javadzadeh, Amir Ghorbanihaghjo, Farzad Adl, D Andalib, Hassan Khojasteh-Jafari, Kamyar Ghabili

PubMed · 2013 · 22 citations · 34 references

Full text

Open access

Abstract

Administration of the CaD in the patients with diabetic retinopathy may reduce the serum levels of endothelin-1 and hsCRP. This might imply amelioration of the endothelial function and inflammatory status following CaD therapy in these patients.

References

34

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

William T. Friedewald, Robert I. Levy, Donald S. Fredrickson · Clinical Chemistry · 1972 · 32.1K citations

, , +19

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine · 1993 · 24.5K citations · Full text

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

R. C. Turner, Charles Fox, Matthews et al. · The Lancet · 1998 · 8.4K citations

, , +10

Lifetime Risk for Diabetes Mellitus in the United States

K.M. Venkat Narayan · JAMA · 2003 · 1.5K citations

Elevated plasma endothelin in patients with diabetes mellitus

Kazuhiro Takahashi, M.A. Ghatei, H.‐C. Lam et al. · Diabetologia · 1990 · 492 citations · Full text

, , +4